Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Maturation and persistence of CAR T cells derived from human pluripotent stem cells via chemical inhibition of G9a/GLP.
Jing R, Falchetti M, Han T, Najia M, Hensch LT, Meader E, Lummertz da Rocha E, Kononov M, Wang S, Bingham T, Li Z, Zhao Y, Frenis K, Kubaczka C, Yang S, Jha D, Rodrigues-Luiz GF, Rowe RG, Schlaeger TM, Maus MV, North TE, Zon LI, Daley GQ. Jing R, et al. Among authors: maus mv. Cell Stem Cell. 2025 Jan 15:S1934-5909(24)00448-X. doi: 10.1016/j.stem.2024.12.008. Online ahead of print. Cell Stem Cell. 2025. PMID: 39818202 No abstract available.
Charting the course for CAR T-cell manufacturing.
Elsallab M, Maus MV. Elsallab M, et al. Among authors: maus mv. Blood Adv. 2024 Dec 10;8(23):6131-6132. doi: 10.1182/bloodadvances.2024014653. Blood Adv. 2024. PMID: 39656474 Free PMC article. No abstract available.
CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual targeting antibody overcome antigen heterogeneity in AML.
Silva H, Martin G, Birocchi F, Wehrli M, Kann MC, Supper VM, Parker A, Graham CE, Bratt AG, Bouffard AA, Donner H, Escobar G, Takei HN, Armstrong A, Goncalves S, Berger TR, Choi BD, Maus MV, Leick MB. Silva H, et al. Among authors: maus mv. Blood. 2024 Nov 21:blood.2023023210. doi: 10.1182/blood.2023023210. Online ahead of print. Blood. 2024. PMID: 39571145
Association of CD19+-targeted chimeric antigen receptor (CAR) T-cell therapy with hypogammaglobulinemia, infection, and mortality.
Sutherland NM, Zhou B, Zhang L, Ong MS, Hong JS, Pak A, Liu KJ, Frigault MJ, Maus MV, Hill JA, Reynolds K, Walter JE, Camargo CA Jr, Barmettler S. Sutherland NM, et al. Among authors: maus mv. J Allergy Clin Immunol. 2024 Nov 4:S0091-6749(24)01165-5. doi: 10.1016/j.jaci.2024.10.021. Online ahead of print. J Allergy Clin Immunol. 2024. PMID: 39505278
Maturation and persistence of CAR T cells derived from human pluripotent stem cells via chemical inhibition of G9a/GLP.
Jing R, Falchetti M, Han T, Najia M, Hensch LT, Meader E, Lummertz da Rocha E, Kononov M, Wang S, Bingham T, Li Z, Zhao Y, Frenis K, Kubaczka C, Yang S, Jha D, Rodrigues-Luiz GF, Rowe RG, Schlaeger TM, Maus MV, North TE, Zon LI, Daley GQ. Jing R, et al. Among authors: maus mv. Cell Stem Cell. 2025 Jan 2;32(1):71-85.e5. doi: 10.1016/j.stem.2024.10.004. Epub 2024 Nov 5. Cell Stem Cell. 2025. PMID: 39504968
Toxicities and outcome after CD19-directed chimeric antigen receptor T-cell therapy for secondary neurolymphomatosis.
Kaulen LD, Karschnia P, Doubrovinskaia S, Abramson JS, Martinez-Lage M, Shankar G, Choi BD, Barnes JA, El-Jawahri A, Hochberg EP, Johnson PC, Soumerai JD, Wick W, Maus MV, Chen YB, Frigault MJ, Dietrich J. Kaulen LD, et al. Among authors: maus mv. Am J Hematol. 2024 Dec;99(12):2411-2415. doi: 10.1002/ajh.27505. Epub 2024 Oct 23. Am J Hematol. 2024. PMID: 39440883
193 results